|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1001 Connecticut Avenue NW |
Address2 | 610 |
City | Washington |
State | DC |
Zip Code | 20036 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 113-12
|
||||||||
|
6. House ID# 300020000
|
TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Michael E. Heintz |
Date | 3/29/2024 1:58:47 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Attend Capitol Hill reception for new NIH Director Monica Bertagnolli. Begin planning for Academy advocacy Hill Day and NIH program officer meetings with early career researchers. Coordinate with Rep. Eshoo office for award of Academy Gold Medal and Medical Imaging Technology Showcase room on Capitol Hill for March 2024. Send invitations for the Medical Imaging Technology Showcase to all Capitol Hill Offices. Hosted annual Medical Imaging Technology Showcase in Rayburn House Office Building. Award Academy Gold Medal to Congresswoman Anna Eshoo at Showcase. Lead cohort of early career researchers to NIH for a campus tour and discussion.
17. House(s) of Congress and Federal agencies Check if None
Natl Institutes of Health (NIH), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Heintz |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Conduct Academy advocacy Hill Day with 38 advocates conducting 60 meetings with House and Senate Offices to encourage FY25 funding for NIH at $51.303 billion, ARPA-H funding at $1.5 billion, and completion of all appropriations efforts on time to avoid disruptions to scientific research. Discussions also included completion of FY24 appropriations process for NIH and ARPA-H. Specific offices met with include: Senator Josh Hawley (MO), Rep. Gary Palmer (AL-6), Rep. Terri Sewell (AL-7), Rep. Bush (MO-1), Senator Schmitt (MO), Senator Britt (AL), Rep. Aderholt (AL-4), Senator Klobuchar (MN), Senator Grassley (IA), Senator T. Smith (MN), Rep. Miller-Meeks (IA-1), Rep. Finstad (MN-1), Rep. Pressley (MA-7), Rep. Dingell (MI-6), Rep. Slotkin (MI-7), Senator Stabenow (MI), Senator Markey (MA), Senator Peters (MI), Senator Blackburn (TN), Rep. Miller (OH-7), Senator Vance (OH), Rep. Green (TN-7), Senator Brown (OH), Rep. Andy Ogles (TN), Rep. Crockett (TX-30), Rep. Doggett (TX-37), Senator Van Hollen (MD), Rep. Mfume (MD-7), Rep. Casar (TX-35), Rep. Levin (CA-49), Rep. Eshoo (CA-16), Senator Mark Warner (VA), Senator Padilla (CA), Senator Elizabeth Warren (MA), Rep. Peters (CA-50), Rep. Mace (SC-1), Senator Scott (SC), Senator Budd (NC), Rep. Foushee (NC-4), Senator Graham (SC), Senator Ron Johnson (WI), Senator Casey, Rep. Moore (WI-4), Rep. Dean (PA-4), Senator Baldwin (WI), Senator Fetterman (PA), Senator Booker (NJ), Senator Gillibrand (NY), Senator Schumer (NY), Rep. Nadler (NY-12), Rep. Balint (VT-at large), Rep. Schrier (WA-8), Senator Cantwell (WA), Senator Warnock (GA), Senator Sanders (VT), Senator Murray (WA), and Senator Welch (VT).
Submitted FY25 programmatic appropriations requestions related to NIH ($51.303 billion) and ARPA-H (separate from NIH) to Congressional offices: Reps: Aderholt, Bush, Cole, DelBene, Granger, Gomez, Jayapal, Matsui, Moolenaar, Pressley, Sewell, Espliat, Peters, Trone, and Palmer. Sens: Baldwin, Britt, Blumenthal, Cardin, Casey, Butler, Fetterman, Murray, Murphy, Peters, Stabenow, Padilla, Durbin, and Van Hollen.
Issued grassroots email alert for individual communication to elected officials concerning NIH and APRA-H appropriations requests for FY25.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Heintz |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |